Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
-
$25,000,000
Company Info
- Founders
- Oriana Papin-Zoghbi
- Company Description
- The first liquid biopsy test that accurately enables early diagnosis of ovarian cancer through the analysis of tumor marker gangliosides. AOA Dx is a biotech company developing cancer diagnostics in the field of women’s health.
- Market
- Healthcare & Wellness
- Coinvestors
- Kube VC,Good Growth Capital
Links